Oregon Institute Of Science And Medicine
- Assets
- $9.1m
- Revenue
- $8.2m
- Investments
- $0.0
- Employees
- 0
- Location
- Cave Junction, OR
- Founding
- 12/1982
- Data as of
- 12/2022
- EIN
- 93-0814898
Organization Overview
Oregon Institute Of Science And Medicine is located in Cave Junction, OR. The organization was established in 1982. According to its NTEE Classification (U50) the organization is classified as: Biological & Life Sciences, under the broad grouping of Science & Technology and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Oregon Institute Of Science And Medicine is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Oregon Institute Of Science And Medicine generated $8.2m in total revenue. This organization has experienced exceptional growth, as over the past 5 years, it has increased revenue by an average of 54.1% each year . All expenses for the organization totaled $865.9k during the year ending 12/2022. While expenses have increased by 1.5% per year over the past 5 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
RESEARCH, DEVELOPMENT & PUBLIC EDUCATION ON THE BIOCHEMISTRY OF MOLECULAR CLOCKS AND THE DEGENERATIVE DISEASES OF AGING, ELEMENTARY SCIENCE EDUCATION, THE EFFECTS OF ENVIRONMENT ON HEALTH AND WELFARE, AND DISASTER PREPAREDNESS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
LABORATORY DEVELOPMENT OF NEW METHODS FOR QUANTITATIVE MEASUREMENT OF PEPTIDE AND PROTEIN DEAMIDATION BY MEANS OF ION CYCLOTRON RESONANCE FOURIER TRANSORM MASS SPECTROMETERY. OUR LABORATORY IS A WORLD LEADER IN DEAMIDATION RESEARCH (AT OISM FOR OVER 30 YEARS AND EARLIER 13 YEARS IN OTHER INSTITUTIONS). THE AMIDES APARAGINYL AND GLUTAMINYL ARE PRESENT IN ALMOST ALL PROTEINS AND SERVE AS MOLECULAR CLOCKS FOR BIOLOGICAL PROCESSES. DURING THE YEAR, WE CONTINUED TO IMPROVE MEASUREMENT TECHNIQUES AND GAINED FURTHER UNDERSTANDING OF BIOLOGICAL PROCESSES.
STUDY OF THE DEAMIDATION OF PROTEINS INVOLVED IN ALZHEIMER'S AND PARKINSON'S DISEASES AND PROTEINS IN HUMAN EYE LENSES THAT ARE INVOLVED IN CATARACT FORMATION. PROTEIN PRECIPITATION IS INVOLVED IN THESE DISEASES. ADDITIONALY, EYE LENS PROTEINS PROVIDE A SYSTEM TO STUDY DEAMIDATION OVER VERY LONG TIME INTERVALS IN A LIVING SYSTEM.
DEVELOPMENT AND ESTABLISHMENT OF A HUMAN SAMPLE BANK TO USE IN MEDICAL DIAGNOSTIC RESEARCH.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Dr Arthur Robinson President | OfficerTrustee | 40 | $0 |
Dr Noah Robinson Treasurer | OfficerTrustee | 60 | $0 |
Dr Jane Orient Secretary | Trustee | 1 | $0 |
Mr Bruce Tippery Director | Trustee | 1 | $0 |
Dr Zachary Robinson Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $8,169,203 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $8,169,203 |
| Total Program Service Revenue | $0 |
| Investment income | $61,034 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $2,611 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $8,232,848 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $5,540 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $832 |
| Advertising and promotion | $0 |
| Office expenses | $3,511 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $44,627 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $145,635 |
| Insurance | $0 |
| All other expenses | $37,280 |
| Total functional expenses | $865,911 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $103,211 |
| Savings and temporary cash investments | $4,988,909 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $94,806 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $1,353,432 |
| Investments—publicly traded securities | $2,560,961 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $9,101,319 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $475 |
| Total liabilities | $475 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $9,100,844 |
| Total liabilities and net assets/fund balances | $9,101,319 |